Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation ; volume:14 ; number:1 ; day:18 ; month:8 ; year:2023 ; pages:1-18 ; date:12.2023
Nature Communications ; 14, Heft 1 (18.8.2023), 1-18, 12.2023
- Urheber
-
Yamanaka, Satoshi
Furihata, Hirotake
Yanagihara, Yuta
Taya, Akihito
Nagasaka, Takato
Usui, Mai
Nagaoka, Koya
Shoya, Yuki
Nishino, Kohei
Yoshida, Shuhei
Kosako, Hidetaka
Tanokura, Masaru
Miyakawa, Takuya
Imai, Yuuki
Shibata, Norio
Sawasaki, Tatsuya
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-40385-9
- URN
-
urn:nbn:de:101:1-2024020210413391176341
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yamanaka, Satoshi
- Furihata, Hirotake
- Yanagihara, Yuta
- Taya, Akihito
- Nagasaka, Takato
- Usui, Mai
- Nagaoka, Koya
- Shoya, Yuki
- Nishino, Kohei
- Yoshida, Shuhei
- Kosako, Hidetaka
- Tanokura, Masaru
- Miyakawa, Takuya
- Imai, Yuuki
- Shibata, Norio
- Sawasaki, Tatsuya
- SpringerLink (Online service)
Ähnliche Objekte (12)
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
Interleukin-6-interleukin-11 receptor chimeras reveal ionomycin-induced proteolysis beyond ADAM10
Biological Assessment and Tests of Activity of Two Novel Proteolysis Targeting Chimeras (PROTACs)
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Hearing chimeras
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
Interleukin-6-interleukin-11 receptor chimeras reveal ionomycin-induced proteolysis beyond ADAM10
Biological Assessment and Tests of Activity of Two Novel Proteolysis Targeting Chimeras (PROTACs)
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Hearing chimeras
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
Interleukin-6-interleukin-11 receptor chimeras reveal ionomycin-induced proteolysis beyond ADAM10
Biological Assessment and Tests of Activity of Two Novel Proteolysis Targeting Chimeras (PROTACs)
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Hearing chimeras